"We were honored to be nominated alongside Google and Vulcan Real Estate."

(The Center Square) – President Joe Biden has promised to keep Americans moving as part of his $2.3 trillion American Jobs Plan to reinvigorate failing infrastructure Oregon and Washington know all too well.

(The Center Square) – A cornerstone of Washington Democrats' climate agenda is now officially dead in the state legislature, leaving the party's green energy dreams in doubt.

REDMOND, Wash., April 13, 2021 /PRNewswire/ -- Microsoft Corp. will publish fiscal year 2021 third-quarter financial results after the close of the market on Tuesday, April 27, 2021, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. Pacific Time.

BELLEVUE, Wash., April 13, 2021 /PRNewswire/ -- Innovega Inc. received SEC qualification for its $15 million Regulation A+ offering which set in motion the conversion of reservations to completed investments. The converted reservations reached the minimum threshold for the offering on April 11.

CHICAGO, April 13, 2021 /PRNewswire/ -- CoinFlip, the leading Bitcoin ATM provider in the world, announced its first-ever expansion into the state of Washington with thirteen new Bitcoin ATMs across the cities of Tacoma and Vancouver. Through CoinFlip, customers will be able to buy Bitcoin, Dogecoin, Ethereum and six other cryptocurrencies with cash while experiencing the lowest fees in the industry and 24/7 customer support.

BELLEVUE, Wash., April 13, 2021 /PRNewswire/ -- Anker Innovations, a global leader in mobile charging and consumer electronics, today announces two products under the AnkerWork product line including the PowerConf C300, Smart AI-enabled HD webcam and the PowerConf S500 Portable Conference Speaker. 

SEATTLE, April 13, 2021 /PRNewswire/ --  Quantivate today announced it hired two new leadership team members to support exponential growth and accelerate innovations in software for governance, risk and compliance (GRC).

BOTHELL, Wash., April 13, 2021 /PRNewswire/ -- Qilu Puget Sound Biotherapeutic Corp. (Sound Biologics), an emerging biotechnology company focused on developing a novel MabPair™ platform for antibody-based combination therapies for the treatment of cancer, inflammation and autoimmune disease, announced a clinical update on its first MabPair product PSB205 at the American Association for Cancer Research (AACR) Annual Meeting. Dr Li Zhang of Sun Yat-Sen University Cancer Centre (SYSUCC), Guangzhou, China presented a poster on Phase 1 Clinical Trial results of PSB205, a combination of anti-PD1 and anti-CTLA-4 antibodies that are manufactured together as a single product, in patients with advanced malignant tumors. The study is sponsored by Qilu Pharma in China.